CCL2 and squamous cell lung carcinoma: When exclusively smokers were examined (thereby enriching the sample for KRAS-mutant patients), high KRAS/CCL2/IL1B expression levels portended 128% increased odds of death in LUAD (Figure 7c, lower left) and continued to have no impact on the survival of patients with squamous cell lung carcinoma (Figure 7c, lower right).